Blog
[printfriendly]
-
Nov 1, 2024November is Diabetes Awareness Month
Diabetes is the main cause of peripheral neuropathy. We’re supporting diabetes awareness month by promoting diabetes education. By learning about what can increase your risk of getting diabetes and the… -
Oct 23, 2024Running Through the Pain: Finding Strength in the Face of Polyneuropathy
by Dieter R. Boston Marathon Tragedy: A Day That Changed Everything The television flickered with images of the elite runners and the wheelchair athletes surging forward, the energy of the… -
Oct 17, 2024Announcing Our New Partnership with Lilly
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This… -
Oct 1, 2024October: Breast Cancer Awareness Month
October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be… -
Aug 28, 2024
Announcing Our Renewed Partnership with Regenesis
We are thrilled to announce Regenesis as a Champion Level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in… -
Aug 12, 2024
Announcing Our Renewed Partnership with CSL Behring
We are thrilled to announce CSL Behring as a Champion level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial… -
Jul 11, 2024Join the NEPTUNE-17 clinical trial for Diabetic Peripheral Neuropathic Pain (DPNP)
Does diabetic peripheral neuropathic pain (DPNP) disrupt your daily life and keep you awake at night despite your current treatment? You are not alone. The NEPTUNE-17 clinical trial, hosted by… -
Jun 25, 2024
Announcing Our New Partnership with GlaxoSmithKline (GSK)
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and GlaxoSmithKline (GSK) as a 2024 Research Impact Partner. This collaboration, with GSK’s generous support,…